The Human Insulin Drug Market is estimated to be valued at US$ 42,283.9 Mn in 2021 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Human insulin drugs are widely used for the treatment of diabetes. These drugs provide an essential treatment option for individuals suffering from both type 1 and type 2 ... Read more
Human insulin drugs are used in the treatment of diabetes by regulating blood sugar levels in patients. It is produced using recombinant DNA technology and acts as a substitute for the insulin produced by the pancreas. Diabetes is a chronic disease that occurs when the pancreas is unable to produce enough insulin or the body cannot effectively use the insulin it produces. This leads to an increase in blood sugar levels. The growing prevalence of diabetes globally has created a surge in ... Read more
Human insulin drugs are used to manage blood sugar levels in diabetes patients. They help to replenish insulin that the body either doesn't produce or doesn't produce enough of. The popularity and need for human insulin drugs is increasing substantially owing to the rising prevalence of diabetes worldwide. According to estimates, approximately 475 million people suffered from diabetes in 2019 and this number is projected to grow to 700 million by 2045.
